Advanced search×

Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study.

Pascale P Massin, Céline C Lange, Jean J Tichet, Sylviane S Vol, Ali A Erginay, Martine M Cailleau, Eveline E Eschwège, Beverley B Balkau, and

Arch Ophthalmol 129(2):188-95 (2011) PMID 21320965 PMCID PMC3317887

To evaluate the predictive values of hemoglobin A(1c) (HbA(1c)) and fasting plasma glucose (FPG) for retinopathy 10 years after the baseline examination.

DOI: 10.1001/archophthalmol.2010.353
Version: za2963e q8za1 q8zb6 q8zcb q8zdd q8zeb q8zf6 q8zg0
View PDF

Similar articles you may find interesting…

  1. Final visual acuity results in the early treatment for retinopathy of prematurity study.
    , William V WV Good, ... Maryann M Redford

    Arch Ophthalmol 128(6):663-71 (2010) PMID 20385926

    These results are particularly important considering that 52% of Type 2 high-risk prethreshold eyes underwent regression of ROP without requiring treatment. Trial Registration clinicaltrials.gov Identifier: NCT00027222....
  2. Editorial Board
    Author(s) unavailable

    Ophthalmology 116(6):0 (2009)

  3. Patient preferences in the treatment of diabetic retinopathy
    Grinspan

    Patient Prefer Adherence (2011) PMID 21660105

    Accounting for patient preferences may be especially important in diabetes mellitus, given the challenge in identifying factors associated with treatment adherence. Although preference studies have been performed in diabetes, none have examined treatments used in diabetic retinopathy...
    View PDF